p-RELA/NF kappa B p65 Antibody (27.Ser 536) and 3 more items

The University of Virginia awarded a contract to Santa Cruz Biotechnology, Inc. on September 5, 2026, under purchase order A207_PO-0477559, with a cumulative value of $1,249.36. The contract encompasses the procurement of four monoclonal antibodies for research purposes, all to be delivered to Cynthia S. Dodson at the University of Virginia in Virginia. The antibodies include p-RELA/Nuclear Factor Kappa B (NF-κB) p65 Antibody (27.Ser 536), RELA/NF-κB p65 Antibody (F-6), p-NFKBIA/Inhibitor of Kappa B Alpha (IκB alpha) Antibody (B-9), and NFKBIA/IκB alpha Antibody (H-4), with each item priced at $312.34 per unit.

The contract represents a straightforward materials procurement supporting the University of Virginia's research operations. Each of the four line items consists of a single unit purchase, totaling four antibody products valued at $1,249.36. These reagents are commonly utilized in immunological and molecular biology research applications focused on the NF-κB signaling pathway. No annual value or specific period of performance beyond the award date is specified in the contract documentation.